Human Escherichia coli O157:H7 genetic marker in isolates of bovine origin

Emerging Infectious Diseases

Volumn 10, Issue 8, 2004, Pages 1482-1485

  LeJeune, Jeffrey T ^a,b   Abedon, Stephen T ^a   Takemura, Kaori ^a   Christie, Nicholas P ^a   Sreevatsan, Srinand ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATE; CATTLE; ESCHERICHIA COLI; GENE; GENETIC MARKER; HUMAN; NONHUMAN; Q GENE; STX2 GENE; TOXIN SYNTHESIS;

EID: 3543008329     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1008.030784     Document Type: Article

References (15)

1. Karmali MA, Arbus GS, Petric M, Patrick ML, Roscoe M, Shaw J, et al. Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse [letter]. Lancet. 1988;1:526.
2. O'Loughlin EV, Robins-Browne RM. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect. 2001;3:493-507.
3. Kimura N, Watanabe M, Komatsubara A. [Verotoxin producing ability of verotoxin-producing Escherichia coli strains isolated from fecal specimens of healthy persons is lower than that of patients]. Kansenshogaku Zasshi. 2000;74:849-51.
4. Pradel N, Boukhors K, Bertin Y, Forestier C, Martin C, Livrelli V. Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients cattle, and food samples in central France. Appl Environ Microbiol. 2001;67:2460-8.
5. Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, Friedman DI. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol. 2001;183:2081-5.
6. Baker DR, Moxley RA, Francis DH. Variation in virulence in the gnotobiotic pig model of O157:H7 Escherichia coli strains of bovine and human origin. Adv Exp Med Biol. 1997;412:53-8.
7. Kim J, Nietfeldt J, Benson AK. Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle. Proc Natl Acad Sci U S A. 1999;96:13288-93.
8. McNally A, Roe AJ, Simpson S, Thomson-Carter FM, Hoey DE, Currie C, et al. Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157. Infect Immun. 2001;69:5107-14.
9. Unkmeir A, Schmidt H. Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun. 2000;68:4856-64.
10. Arber W, Enquist L, Hohn B, Murray K, Murray N. Experimental methods. In: Hendrix R, Roberts J, Stahl F, Weisberg R, editors. Lambda II. Cold Springs Harbor (NY): Cold Spring Harbor Laboratory; 1983.
11. Schmidt H, Scheef, J, Morabito S, Caprioli A, Wieler LH, Karch H. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol. 2000;66:1205-8.
12. Dorn CR, Angrick E. Serotype O157:H7 Escherichia coli from bovine and meat sources. J Clin Microbiol. 1991;29:1225-31.
13. Locking M. HUS rates in Scotland. Glasgow: Scottish Centre for Infection & Environmental Health; 2002.
14. Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child. 2001;85:125-31.
15. Karch H, Russmann H, Schmidt H, Schwarzkopf A, Heesemann J. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol. 1995;33:1602-5.